Ovid 19 Vaccine For Children Between 2 18 Years News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The journal said that the domestically developed vaccine is “safe, well-tolerated and immunogenic in pediatric subjects.” Bharat Biotech confirmed the development in a tweet. 

Indian council of medical researchBharat biotechIndian councilMedical researchCovid 19 vaccineBharat biotechBharat biotech covid 19 vaccineBharat biotech covaxinCovaxin for childrenOvaxin for children between 2 18 yearsCovid 19 vaccine for childrenOvid 19 vaccine for children between 2 18 yearsThe lancet